论文部分内容阅读
目的观察低分子肝素钙在治疗不稳定型心绞痛(UAP)中的临床疗效及预后判定。方法根据WHO的UAP诊断标准,对41例UAP患者应用低分子肝素钙进行抗凝治疗。以心绞痛的发作次数、持续时间、常规心电图改变,进行临床观察。结果应用低分子肝素钙治疗不稳定型心绞痛,通过观察心电图的变化、临床症状的改善,对UAP患者的治疗有肯定的疗效。结论治疗不稳定型心绞痛应用抗凝方法(经t检验,p<0.05)疗效显著,明显控制了心绞痛发作频率及时间,并有效预防和防止了心肌梗死(AMI)的发生及心脏猝死。
Objective To observe the clinical effect and prognosis of low molecular weight heparin in the treatment of unstable angina pectoris (UAP). Methods According to WHO UAP diagnostic criteria, 41 cases of UAP patients with low molecular weight heparin calcium anticoagulant therapy. The number of episodes of angina pectoris, duration, conventional ECG changes, clinical observation. Results The application of low molecular weight heparin calcium in the treatment of unstable angina pectoris, by observing the changes of electrocardiogram, clinical symptoms, the treatment of UAP patients have a positive effect. Conclusion The treatment of unstable angina with anticoagulant method (t test, p <0.05) has obvious curative effect, obviously controls the frequency and time of angina pectoris, and effectively prevents and prevents the occurrence of myocardial infarction (AMI) and sudden cardiac death.